Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PATH-wSP Dose-Finding Study in Healthy Kenyan Adults and Toddlers
NCT02097472Phase 2Completed
- Sponsor
- PATH
- Start
- Apr 2014
- Primary completion
- Dec 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of wSp vaccine in Pneumococcal pneumonia (PP), sponsored by PATH. Started Apr 2014; status: completed.
02
Drugs
wSp vaccine
03
Conditions
Pneumococcal pneumonia (PP)
Beyond the preview
Go deeper on NCT02097472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02097472.